Share Name Share Symbol Market Type Share ISIN Share Description
AstraZeneca LSE:AZN London Ordinary Share GB0009895292 ORD SHS $0.25
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -112.00p -2.45% 4,468.50p 4,470.50p 4,471.00p 4,563.00p 4,464.50p 4,545.00p 4,127,015.00 16:35:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 16,768.9 2,082.9 151.3 24.7 56,525.80

AstraZeneca Share Discussion Threads

Showing 10176 to 10195 of 10200 messages
Chat Pages: 408  407  406  405  404  403  402  401  400  399  398  397  Older
DateSubjectAuthorDiscuss
18/1/2017
20:37
Luck with that H , very distressing. Hope it all works out as soon as possible.
philanderer
18/1/2017
19:35
everyone I have fallen out with CMC Markets,because I sent them money in December that does not seem to have arrived. My Bank said it " went" be very careful as there could be goings on at such places. I'm not trying to make capital here, just my money back. I have contacted the Financial Services Ombudsman who are taking up my case.
hectorp
18/1/2017
16:53
AstraZeneca Receives 2017 CSO50 Award for use of Skyhigh Networks in Cloud Security Project HTTP://www.businesswire.com/news/home/20170118005338/en/AstraZeneca-Receives-2017-CSO50-Award-Skyhigh-Networks
philanderer
18/1/2017
13:59
18th jan Deutsche buy tp 6000p reiterates
philanderer
17/1/2017
13:38
IC update: AstraZeneca (AZN) has announced an extension of its high profile cancer drug trial MYSTIC. The trial had been investigating the potential of durvalumab as the first choice treatment to reduce progression free survival of lung cancer, but now the trial will assess overall survival of the same patients, giving Astra the opportunity to expand the drug’s label. Buy HTTP://www.investorschronicle.co.uk/2017/01/17/shares/news-and-analysis/news-tips-astrazeneca-hotel-chocalat-greggs-more-ohaa35Nt1wERejhzqlLESK/article.html
philanderer
17/1/2017
10:41
Astrazeneca Amends, Expands, Initiates Trials In 1st-line NSCLC IO Programme Read more: HTTP://www.nasdaq.com/article/astrazeneca-amends-expands-initiates-trials-in-1stline-nsclc-io-programme-20170117-00065#ixzz4W0x60P8Y
philanderer
17/1/2017
09:53
17th jan Liberum hold tp 5200p
philanderer
16/1/2017
20:11
Zacks Investment Research upgraded AstraZeneca plc (ADR) (NYSE:AZN) to Hold in a statement released earlier today HTTP://breakingfinancenews.com/investing/zacks-investment-research-upgraded-astrazeneca-plc-adr-nyseazn-to-hold-in-a-statement-released-earlier-today/155261/
philanderer
13/1/2017
18:45
Adding AstraZeneca To Our Model Portfolio HTTP://seekingalpha.com/article/4036657-adding-astrazeneca-model-portfolio
philanderer
13/1/2017
13:47
13th jan Jefferies buy tp 5400p reiterates
philanderer
12/1/2017
20:47
AstraZeneca Appoints New Head of Oncology HTTP://www.pharmexec.com/astrazeneca-appoints-new-head-oncology
philanderer
12/1/2017
10:05
12th jan ShoreCap hold retains
philanderer
11/1/2017
20:26
Trading @ 4636p stateside
philanderer
11/1/2017
17:50
Evening H.... I reckon Hilary would have been just as bad ;-) As ever , all down to the pipeline.
philanderer
11/1/2017
17:27
Hi phil. TRUMP just finished talking.. he'll hit PHARMA to bring the price of drugs right down. This is very significant for AZN etc, but more so the US pharmas. I see AZN fell there as said may not be so bad for British pharma.
hectorp
11/1/2017
15:16
11th jan UBS buy tp 5000p reiterates
philanderer
10/1/2017
13:09
Well a much better start to the year than I anticipated, welcome and hopefully it lasts and my cautious is misplaced.
essentialinvestor
08/1/2017
11:09
Short article in the Sunday Times may be of interest. "Astra Zeneca, Britain’s second-biggest drugs company, has quietly begun filing patents to protect advances it has made with a revolutionary new gene-editing technology." Http://www.thetimes.co.uk/edition/business/astra-zeneca-pins-hopes-on-gene-editing-revolution-njfxm5jtc
pj84
05/1/2017
20:06
AstraZeneca acquires biotech’s unique antithrombotic drug HTTP://www.pharmafile.com/news/512136/astrazeneca-acquires-biotech-s-unique-antithrombotic-drug Shell, AstraZeneca Could Surprise in 2017, Credit Suisse Says HTTPS://www.thestreet.com/story/13940675/1/2-stocks-named-as-potential-surprises-for-2017-are-worth-the-risk.html
philanderer
05/1/2017
17:57
AZN - One of Hargreaves Lansdowne`s '5 to watch for 2017'
philanderer
Chat Pages: 408  407  406  405  404  403  402  401  400  399  398  397  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:33 V: D:20170120 03:49:17